"Are peptides safe" is the wrong question. A peptide molecule synthesised correctly, identified by mass spectrometry, and purified to 99% has one risk profile. The unidentified contents of a $40 vial from an unknown manufacturer has another. Here is what the LabDoc dataset, peer-reviewed literature, and Australian poisons centres actually show about peptide risk, and the levers that materially reduce it.
Three failure modes that matter
1. Identity failure (it isn't what the label says)
The single most common reason a vial harms someone is that the molecule in the vial is not the molecule on the label. LC-MS identity testing is the only test that catches this. Across the independent CoAs LabDoc has aggregated, a meaningful share of "research" vials either fail identity outright or come back as an unrelated peptide entirely. See the live AU purity dataset.
2. Low purity and unknown impurities
Research-grade peptides should test ≥97% by HPLC with a clean chromatogram. Anything below ~95% means a non-trivial portion of every dose is something else: synthesis by-products, deletion sequences, residual solvents. Those impurities are what drive most of the local injection-site reactions, redness, and sterile abscesses people describe online.
3. Endotoxin / sterility failure
Peptide powder reconstituted in non-sterile water, or manufactured without endotoxin control, can cause systemic inflammatory responses (fevers, chills, malaise) within hours of injection. Reputable third-party labs report endotoxin in EU/mg; consumer vendors almost never publish this number. Australian poisons centres see this every quarter.
What the molecule itself does vs what the vial does
The pharmacology of a correctly manufactured peptide (e.g. semaglutide, tirzepatide, BPC-157) is reasonably well-characterised in published literature and trial data. The risk people meaningfully reduce by testing their vial is not the pharmacology: it's the manufacturing risk: identity, purity, content, and endotoxin. A real vial of semaglutide injected at the wrong dose carries known clinical risks. An unidentified peptide injected at any dose carries unknown risks.
What independent testing changes
Identity (LC-MS): confirms the measured mass matches the theoretical mass of the labelled peptide within a few daltons. If this fails, nothing else matters.
Purity (HPLC): quantifies how much of the vial is the labelled molecule vs everything else. ≥97% is the research-grade threshold.
Peptide content (Quant HPLC): measures the actual mg of peptide vs the labelled mg. Catches under-filling and salt/water dilution.
Endotoxin (LAL): EU/mg. Required for anything injected. Most vendor CoAs omit this; it's the test most worth asking for.
The bare-minimum risk-reduction stack
Don't inject anything you haven't seen a recent third-party CoA for, tied to the exact batch number on the vial. Read how to read a peptide CoA.
If the vendor's CoA is identity-only or purity-only, get the missing test done independently. LabDoc tests a vial for A$549.
Use bacteriostatic water from a pharmacy (not pond water from AliExpress), syringes with intact packaging, and refrigerate reconstituted product.
Stay on a single batch once you've verified it. Re-test when you start a new batch.
What LabDoc actually publishes
Every vial submitted to LabDoc is tested by an independent Australian partner laboratory and the raw chromatogram is preserved on the public certificate. We don't edit numbers, we don't accept payment from vendors to change a result, and we tag Pass / Needs Review / Fail strictly against the documented methodology. The live AU result feed is the most direct way to see, batch by batch, which vendors and which peptides are actually clearing the bar this quarter.
Frequently asked questions
What's the most common reason peptides cause problems?
Manufacturing failure, not pharmacology. Identity mismatches, low purity, and undisclosed endotoxin contamination drive the majority of injection-site reactions and acute responses people report. Independent LC-MS and HPLC testing catches the first two; LAL testing catches the third.
Is a vendor's CoA enough to trust a peptide?
Only if the lab named on the CoA is a real third-party laboratory, the batch number matches your vial, and the report was issued recently. Re-using an old CoA across many batches is the most common form of CoA fraud. When in doubt, get the vial independently tested.
What purity is considered safe for peptides?
Research-grade peptides should read ≥97% purity by HPLC with a clean single peak. Below 95% means at least 5% of every dose is impurity. That's the band where injection-site reactions become common.
Does LabDoc recommend any peptide for human use?
No. LabDoc is a testing aggregator, not a clinic or pharmacy. We publish independent CoAs so researchers, patients and prescribers can verify what's in a vial. Decisions about human use should be made with a registered medical practitioner, see our liability statement.